4//SEC Filing
McFadden Michael E. 4
Accession 0001209191-18-055412
CIK 0001740547other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:08 PM ET
Size
5.5 KB
Accession
0001209191-18-055412
Insider Transaction Report
Form 4
McFadden Michael E.
CCO of Urovant Sciences, Inc.
Transactions
- Award
Stock Option (Right to Buy)
2018-10-15+4,750→ 4,750 totalExercise: $13.65Exp: 2028-10-14→ Common Shares (4,750 underlying)
Footnotes (1)
- [F1]25% of the total shares underlying the option shall vest and become exercisable on October 1, 2019; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
Documents
Issuer
Urovant Sciences Ltd.
CIK 0001740547
Entity typeother
Related Parties
1- filerCIK 0001748333
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:08 PM ET
- Size
- 5.5 KB